8-oxo-7-(propan-2-ylideneamino)-3-propyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
C13H18N2O3S — CID 174494144
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-oxo-7-(propan-2-ylideneamino)-3-propyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
8-oxo-7-(propan-2-ylideneamino)-3-propyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (PubChem CID 174494144) has the molecular formula C13H18N2O3S and a molecular weight of 282.36 g/mol. Its IUPAC name is 8-oxo-7-(propan-2-ylideneamino)-3-propyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid.
Molecular Properties
| Compound Name | 8-oxo-7-(propan-2-ylideneamino)-3-propyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
|---|---|
| PubChem CID | 174494144 |
| Molecular Formula | C13H18N2O3S |
| Molecular Weight | 282.36 g/mol |
| Exact Mass | 282.10 |
| IUPAC Name | 8-oxo-7-(propan-2-ylideneamino)-3-propyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| SMILES | CCCC1=C(C(=O)O)N2C(=O)C(N=C(C)C)C2SC1 |
| InChI | InChI=1S/C13H18N2O3S/c1-4-5-8-6-19-12-9(14-7(2)3)11(16)15(12)10(8)13(17)18/h9,12H,4-6H2,1-3H3,(H,17,18) |
| InChIKey | JOAFJTQRGZPVGG-UHFFFAOYSA-N |
| XLogP | 1.89 |
| TPSA | 69.97 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 19 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 282.36 |
| LogP ≤ 5 | 1.89 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 174494144 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.